Dr. Martin reviewed stage III NSCLC resectability, stressing N2 nodal patterns, induction response, minimally invasive surgery, and multidisciplinary decision-making. Dr. Daly reviewed open questions on radiation plus immunotherapy in lung cancer, noting benefit of consolidation, mixed results with concurrency, and ongoing trials refining strategy. The Q & A session stressed invasive mediastinal staging for larger or central lung tumors, role of EBUS/mediastinoscopy, frailty, PET nodes, and need for better trials.